nad has been researched along with Hypertension, Pulmonary in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dobrinskikh, E; Gandjeva, A; Hu, CJ; Kumar, S; Laux, A; Li, M; McKeon, BA; Plecitá-Hlavatá, L; Prasad, RR; Riddle, S; Stenmark, KR; Tuder, RM; Zhang, H | 1 |
| Chelvanambi, S; Frump, AL; Hester, JM; Lahm, T; Sharma, S | 1 |
| Alruwaili, N; Kandhi, S; Sun, D; Wolin, MS | 1 |
| Hanif, K; Kaur, G; Lingeshwar, P; Siddiqui, HH; Singh, N | 1 |
| Chang, MS; Kourembanas, S; Mitsialis, SA; Wu, X | 1 |
1 review(s) available for nad and Hypertension, Pulmonary
| Article | Year |
|---|---|
Metabolism and Redox in Pulmonary Vascular Physiology and Pathophysiology.
Topics: Animals; Blood Vessels; Cyclic GMP; Glucosephosphate Dehydrogenase; Glycolysis; Humans; Hypertension, Pulmonary; Lactic Acid; NAD; Oxidation-Reduction; Reactive Oxygen Species | 2019 |
4 other study(ies) available for nad and Hypertension, Pulmonary
| Article | Year |
|---|---|
SIRT3 Is a Critical Regulator of Mitochondrial Function of Fibroblasts in Pulmonary Hypertension.
Topics: Animals; Cattle; Fibroblasts; Humans; Hypertension, Pulmonary; Mitochondria; Mitochondrial Proteins; NAD; Sirtuin 3 | 2023 |
Slide-Seq for Spatially Mapping Gene Expression. Metabolic Syndrome Exacerbates Group 2 Pulmonary Hypertension, and NAD Metabolism Is Influenced by Tissue Origin.
Topics: Gene Expression; Humans; Hypertension, Pulmonary; Metabolic Syndrome; NAD | 2020 |
Poly (ADP-ribose) polymerase-1: an emerging target in right ventricle dysfunction associated with pulmonary hypertension.
Topics: Adenosine Triphosphate; Animals; Apoptosis; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; In Situ Nick-End Labeling; Isoquinolines; Male; Mitochondria; Mitochondrial Membranes; Monocrotaline; NAD; Oxidative Stress; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Rats; Rats, Sprague-Dawley; Tissue Inhibitor of Metalloproteinase-2; Ventricular Dysfunction, Right | 2015 |
Hypoxia regulates bone morphogenetic protein signaling through C-terminal-binding protein 1.
Topics: Alcohol Oxidoreductases; Bone Morphogenetic Protein Receptors, Type II; Bone Morphogenetic Proteins; Carrier Proteins; Cells, Cultured; DNA-Binding Proteins; Humans; Hypertension, Pulmonary; Hypoxia; Inhibitor of Differentiation Protein 1; Myocytes, Smooth Muscle; NAD; Phosphoproteins; Pulmonary Artery; Signal Transduction; Transcription Factors; Transcription, Genetic | 2006 |